Grünenthal announces joint venture collaboration with Kyowa Kirin
Under the collaboration, all the products in the portfolio will continue to be marketed through affiliates in seven…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
03 Aug 23
Under the collaboration, all the products in the portfolio will continue to be marketed through affiliates in seven…
03 Aug 23
The patent provides protection of the enema formulation of cobitolimod, that is currently under evaluation in the ongoing…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Aug 23
The three-year agreement includes a joint request to dismiss with prejudice the pending litigation between the companies, including…
02 Aug 23
LX2020 is an AAV-based gene therapy that works by intravenously delivering a functional PKP2 gene to increase the…
02 Aug 23
Anser TDM services, a range of homogenous mobility shift tests, are said to be useful for clinicians who…
02 Aug 23
The transaction is intended to add more than $1bn in net cash to Revolution Medicines’ balance sheet and…
02 Aug 23
Under the terms of the agreement, ProQR will get an initial payment of €12.5m and will also be…
02 Aug 23
Neuraxpharm’s dedicated neurology focus and established European presence makes them an attractive partner for BRIUMVI’s European launch, targeted…
02 Aug 23
Phase 2 study initiated at clinical sites in Australia with monovalent and bivalent mRNA COVID-19 vaccine candidates
01 Aug 23
The combination of Jemperli and chemotherapy consisting of carboplatin and paclitaxel has been indicated for patients having primary…